FMC7 Immunophenotyping by Flow Cytometry Test
Comprehensive Introduction to FMC7 Immunophenotyping
Immunophenotyping by Flow Cytometry FMC7 represents a cutting-edge diagnostic approach in modern hematology and oncology. This sophisticated laboratory technique enables precise identification and characterization of specific cell populations within blood and bone marrow samples. The FMC7 test specifically targets a unique antigen expressed on mature B-lymphocytes, providing clinicians with invaluable insights into hematologic disorders and malignancies.
The importance of FMC7 immunophenotyping cannot be overstated in contemporary cancer diagnostics. By accurately distinguishing between different types of B-cell malignancies, this test directly influences treatment decisions, prognosis assessment, and disease monitoring strategies. The ability to detect subtle cellular changes at the molecular level makes FMC7 testing an essential tool in the comprehensive evaluation of lymphoid disorders.
What the FMC7 Test Measures and Detects
The FMC7 immunophenotyping test specifically identifies and quantifies the presence of the FMC7 antigen on the surface of B-lymphocytes. This antigen serves as a crucial marker for distinguishing between various B-cell malignancies:
- Detection of FMC7 antigen expression on mature B-cells
- Differentiation between chronic lymphocytic leukemia (CLL) and other B-cell lymphomas
- Identification of specific B-cell subsets and their maturation stages
- Quantification of abnormal cell populations in blood and bone marrow
- Assessment of B-cell immunophenotypic patterns for diagnostic classification
Who Should Consider FMC7 Immunophenotyping Testing
This specialized test is recommended for individuals presenting with specific clinical indications and symptoms that may suggest hematologic malignancies:
Clinical Indications
- Patients with unexplained lymphocytosis or abnormal lymphocyte counts
- Individuals showing signs of B-cell disorders or lymphoid malignancies
- Patients requiring differential diagnosis between CLL and other B-cell lymphomas
- Individuals with persistent fatigue, unexplained weight loss, or night sweats
- Patients with enlarged lymph nodes, spleen, or liver without clear cause
- Those with recurrent infections or abnormal bleeding tendencies
Specialist Recommendations
Oncologists and hematologists typically order FMC7 immunophenotyping when:
- Initial blood tests reveal abnormal lymphocyte morphology
- There’s suspicion of B-cell lineage hematologic malignancies
- Accurate classification of lymphoid neoplasms is required
- Treatment response monitoring is necessary for existing diagnoses
Significant Benefits of FMC7 Immunophenotyping
Choosing FMC7 immunophenotyping provides numerous advantages for both patients and healthcare providers:
- Precise Diagnosis: Enables accurate differentiation between similar-appearing B-cell malignancies
- Treatment Guidance: Informs targeted therapy selection based on specific cell markers
- Prognostic Value: Provides important information about disease progression and outcomes
- Rapid Results: Same-day reporting allows for timely clinical decisions
- Minimal Sample Requirement: Requires only small blood or bone marrow volumes
- Comprehensive Analysis: Offers detailed cellular characterization beyond routine testing
Understanding Your FMC7 Test Results
Interpreting FMC7 immunophenotyping results requires specialized medical expertise, but general understanding can help patients:
Positive FMC7 Expression
- Typically indicates mature B-cell phenotype
- Suggests conditions other than typical CLL
- May point toward mantle cell lymphoma or other B-cell neoplasms
- Requires correlation with other clinical and laboratory findings
Negative FMC7 Expression
- Commonly associated with chronic lymphocytic leukemia
- Supports CLL diagnosis when combined with other characteristic markers
- Helps distinguish CLL from other B-cell lymphoproliferative disorders
Important Considerations
- Results should always be interpreted by qualified hematologists or oncologists
- FMC7 findings are part of comprehensive immunophenotypic analysis
- Clinical context and additional testing are essential for accurate diagnosis
- Follow-up testing may be recommended based on initial findings
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $88 |
| Regular Price | $112 |
Turnaround Time and Sample Requirements
- Turnaround: Sample accepted daily by 9 AM; Same-day reporting
- Sample Type: 3 mL whole blood in Lavender Top (EDTA) tube AND 3 mL whole blood in Green Top (Sodium Heparin) tube OR 2 mL Bone marrow in Green Top (Sodium heparin) tube
- Shipping: Immediate shipment at 18-22°C – DO NOT REFRIGERATE OR FREEZE
- Documentation: Specify time, date, and clinical details on test request form
Nationwide Testing Availability
We maintain comprehensive testing facilities across the United States, ensuring accessible FMC7 immunophenotyping services in all major metropolitan areas. Our network includes specialized centers in:
- New York City and surrounding tri-state area
- Los Angeles and Southern California region
- Chicago and Midwest locations
- Houston, Dallas, and Texas facilities
- Miami and Florida diagnostic centers
- Seattle, Portland, and Pacific Northwest locations
- Boston, Philadelphia, and Northeast regions
Take Action for Your Health Today
Don’t wait to get the answers you need for proper diagnosis and treatment. Our FMC7 immunophenotyping test provides the critical information your healthcare team requires to make informed decisions about your care.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your test or speak with our specialist coordinators. We’ll help you understand the testing process, assist with insurance questions, and ensure you receive the comprehensive care you deserve.
With same-day results and expert interpretation available, you can move forward with confidence in your diagnostic journey. Trust the precision of FMC7 immunophenotyping to provide the clarity needed for effective hematologic management.
